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e.2013.03Abstract Objective: ICU acquired muscle weakness (ICUAMW) is an acquired neuromuscular
disorder associated with increased duration of mechanical ventilation and weaning suggesting a
possible relation between the limb and respiratory neuromuscular involvement. There is no preven-
tive tool and no speciﬁc treatment has been proposed for ICU acquired muscle weakness. Aim of
this study was to assess the effect of electrical muscle stimulation on prevention of ICUAMW and
in facilitating the weaning from mechanical ventilation in critically ill patients.
Design: A prospective, randomized, placebo-controlled trial.
Setting: Critical care department, main Alexandria university hospital.
Patients: 80 Critically ill patients on mechanical ventilation for more than 24 h.
Methods: They were randomly categorized into two groups: 40 patients received conventional lines
of treatment only (control group) and 40 patients received in addition one daily session of Electrical
Muscle Stimulation (EMS) (EMS group). Assessment of occurrence of ICUAMW was done
through the MEDICAL RESEARCH COUNCIL SCALE (MRCS) which is a method for clinical
assessment of muscle strength.red muscle weakness; EMS,
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310 H.A. Abu-Khaber et al.Results: MRCS did not show any signiﬁcant difference between the two groups in the ﬁrst 3 days
post mechanical ventilation while on day 4, MRCS mean value was 46.86 ± 10.88 in the EMS
group versus 43.70 ± 9.32 in the control group (p= 0.041). On day 21, MRCS mean value was
29.67 ± 8.87 in the EMS group versus 19.60 ± 4.34 in the control group (p= 0.037). Signiﬁcant
difference was also noted in the duration of mechanical ventilation as the mean value in the
EMS group was 9.01 ± 8.01 days versus 11.97 ± 8.07 in the control group (p= 0.048).
Conclusions: Although the EMS could not prevent the occurrence of ICUAMW in critically ill
mechanically ventilated patients it still has a role in minimizing the degree of muscular weakness
and could be helpful in facilitating weaning from mechanical ventilation.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Alexandria University Faculty of Medicine.1. Introduction
The ICU acquired muscle weakness (ICUAMW) is an
acquired neuromuscular disorder which is considered a com-
mon complication of critical illness survivors presenting with
profound muscle weakness and diminished or absent deep ten-
don reﬂexes which are associated also with increased duration
of mechanical ventilation and weaning period suggesting a
possible relation between the limb and respiratory neuromus-
cular involvement. In addition, the syndrome is associated
with prolonged hospitalization and increased mortality. The
diagnosis of ICUAMW requires a reliable bedside muscle
strength examination and depends on patient’s cooperation
and maximal effort.1,2
There is no preventive tool and no speciﬁc treatment has
been proposed so far for ICU acquired muscle weakness but
there are several risk factors that have been identiﬁed and
should be adjusted. The risk factors include systemic inﬂam-
matory response and sepsis, medications such as corticoste-
roids and neuromuscular blocking agents, inadequate
glycemic control, protracted immobility, hypoalbuminemia,
gram-negative bacteraemia and severity of organ dysfunction
and also electrolyte disorders.3,4
A number of studies have evaluated the role of early mobi-
lization and/or physiotherapy in critically ill patients. These
studies involved passive limb mobilization, limb and
respiratory muscle training, and bed cycling. Although favor-
able results in terms of muscle strength, mobilization, six-
minute walking distance and length of hospital stay have been
shown, the development of ICUAMW was not evaluated.5,6
It is also noteworthy that limb and respiratory muscle train-
ing requires patient cooperation.7
Many studies reported beneﬁcial effects of Electrical
Muscle Stimulation (EMS) on ICU acquired muscle weakness.
The pathophysiological mechanisms that appear to improve
muscle power and facilitate weaning from mechanical ventila-
tor could be that EMS acts as an anabolic stimulus to the mus-
cle reversing the catabolic effects of critical illness and
immobilization that is to say EMS has beneﬁcial effects on
muscle metabolism and also it improves oxygen uptake
(VO2) kinetics and work efﬁciency.
8,9
Also EMS applied to the lower limbs of critically ill patients
induced an acute systemic effect on the microcirculation as as-
sessed with the near infrared spectroscopy technique, indicat-
ing the presence of factors induced by EMS, that act in a
systemic way. It is possible that molecules such as cytokines,
produced at the loci of EMS and distributed via the circulation
could be responsible for the systemic effect of EMS in prevent-ing ICUAMW. Several cytokine levels, primarily IL-6 have
been shown to increase after exercise. IL-6 mRNA has been
shown to increase after an EMS session in rat skeletal
muscles.10,11
Moreover, it is possible that central command and activa-
tion of metabo-reﬂex and/or ergo-reﬂex during EMS may
increase sympathetic discharge and contribute to changes in
heart rate, systolic blood pressure, blood volume and cardiac
output, and therefore affect the skeletal muscle metabolism
in a systemic way.12 Finally, a bio-energetic pathway may be
activated during EMS contributing to an improvement in
mitochondrial function of the skeletal muscle.13
2. Aim of the work
The aim of this work was to assess the effect of electrical mus-
cle stimulation in:
1. Prevention of ICUAMW in critically ill patients.
2. Facilitating the weaning from mechanical ventilation in
critically ill patients.
3. Patients
The present study was carried out on 80 critically ill patients
on mechanical ventilation for more than 24 h admitted to
the critical care medicine department of Alexandria University
Hospital in Egypt.
3.1. Exclusion criteria
1. Age under 18 years.
2. Pregnancy.
3. Obesity (body mass index >35 kg/m2).
4. Pre-existing neuromuscular disease.
5. Patients receiving muscle relaxant.
6. Diseases with systemic vascular involvement such as sys-
temic lupus erythematosus.
7. Technical obstacles that do not allow the implementa-
tion of EMS such as bone fractures or skin lesions
(e.g. burns).
8. End-stage malignancy.
9. Patients with cardiac pacemakers.
10. Patients with cervical spine fractures, hemiplegia, quad-
riplegia of neurological origin.
Figure 1 EMS equipment.
Table 2 Grading of muscle strength according to MRCS.
Table 1 Functions assessed in MRCS.
Upper limb Wrist ﬂexion Grade 0–5 X2 (RT&LT)
Forearm ﬂexion Grade 0–5 X2 (RT&LT)
Shoulder abduction Grade 0–5 X2 (RT&LT)
Lower limb Ankle dorsiﬂexion Grade 0–5 X2 (RT&LT)
Knee extension Grade 0–5 X2 (RT&LT)
Hip ﬂexion Grade 0–5 X2 (RT&LT)
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score due to the impaired cognitive state.
Æ Patients were randomly categorized into two groups:
a. Group I: Forty patients received conventional lines of
treatment only.
b. Group II: Forty patients received conventional lines of
treatment in addition to one daily session of electrical
muscle stimulation.
4. Methods
Written informed consents were obtained from all patients’ rel-
atives and the approval of local ethics committee was also
obtained.
4.1. Selection of the patients
All patients in the study were subjected to the following:
1. Full history taking.
2. Complete physical examination.
3. Body mass index according to the equation: BMI = body
weight (in kg) ‚ height (in squared meters)
4. Radiological examination in the form of chest X-ray.
5. Laboratory investigations
6. Identiﬁcation of the patient’s main diagnosis and reason for
mechanical ventilation.Grade 5 Full active range of motion & normal muscle resistance
Grade 4 Full active range of motion & reduced muscle resistance
Grade 3 Full active range of motion & no muscle resistance
Grade 2 Reduced active range of motion & no muscle resistance
Grade 1 No active range of motion & palpable muscle contraction
Grade 0 No active range of motion & no palpable muscle
contraction4.2. Technique
EMS was implemented simultaneously on the quadriceps mus-
cles of both lower extremities starting from the second day
after admission using the pointer probe. The stimulator
delivered biphasic, symmetric impulses of 50 Hz, 200 ls pulse
duration, 15 s on (including 1 s rise time and 1 s fall time)
at intensities able to cause visible contractions (mostly
100–150 MA). In case of doubt, contraction was conﬁrmed
by palpation of the muscles involved. The session was done
once daily for a period of 1 h including 5 min for warm up
and 5 min for recovery.14
4.3. Equipment:
Fig. 1
 Model: Dr. Eldakr Digital Electronic Acupunctoscope.
 Site of production: Hong Kong.
 Name of company: 2D trading company.
 Frequency of muscle stimulation: two frequency ranges set-
ting from 1 to100 Hz and from 10 to 999 Hz.
 Components:
n Hard carrying case.
n Dr. Eldakr Digital Electronic Acupunctoscope.
n 3.5 mm plug connecting wire of alligator type (4 pieces)
n Pointer probe with hand grip electrode.
n 9 V battery (pp3, 6f22).
Assessment of occurrence of ICUAMW was done through
the MEDICAL RESEARCH COUNCIL SCALE (MRCS)which is a method for clinical assessment of muscle strength.15
After interruption of sedation, patients were screened daily for
awakening and comprehension for a period of 28 days or until
the time of weaning from mechanical ventilation each of which
is nearer. MRCS was assessed on the day the patients had a
level of consciousness adequate to respond to at least three
of the following orders (‘open/close your eyes’, ‘look at me’,
‘put out your tongue’, ‘nod your head’, ‘raise your eye-
brows’).16 Three muscle groups in all four limbs were assessed
with the MRC scale with values ranging from 0 (quadriplegia)
to 60 (normal muscle strength).17 The functions assessed are
shown in Table 1 and grading of muscle strength according
to MRCS is shown in Table 2.
Patients with an MRC score of less than 48 of 60 were diag-
nosed with ICUAMW. The cut-off limit of 48 for the MRC
score was selected because it indicates clinically signiﬁcant
weakness and has been used previously for the clinical identi-
ﬁcation of ICU-acquired paresis.18
4.4. Measurements
Comparison between the two groups of patients regarding the
MRCS and duration of weaning from mechanical ventilator.
Table 4 Comparison between the two studied groups regard-
ing MRCS at different periods of follow up.
MIRCS at EMS group Control group t-value p
Day 2
Range 32.00–58.00 38.00–60.00
Mean ± S.D 49.28 ± 6.88 50.23 ± 5.51 0.465 0.497
Day 3
Range 20.00–60.00 28.00–59.00
Mean ± S.D 45.25 ± 9.64 46.43 ± 7.21 1.781 0.094
Day 4
Range 21.00–60.00 18.00–60.00
Mean ± S.D 46.86 ± 10.88 43.70 ± 9.32 1.888 0.041*
Day 5
Range 20.00–60.00 12.00–60.00
Mean ± S.D 45.83 ± 11.39 40.69 ± 10.48 1.998 0.044*
Day 6
Range 22.00–60.00 12.00–58.00
Mean ± S.D 43.00 ± 12.07 39.63 ± 10.30 1.817 0.046*
Day 7
Range 19.00–57.00 17.00–50.00
Mean ± S.D 43.37 ± 9.85 37.27 ± 13.43 1.848 0.049*
Day 14
Range 12.00–57.00 21.00–51.00
Mean ± S.D 37.91 ± 11.14 32.89 ± 16.89 1.231 0.047*
Day 21
Range 14.00–26.00 20.00–42.00
Mean ± S.D 29.67 ± 8.87 19.60 ± 4.34 2.009 0.037*
Day 28
Range 14.00–29.00 19.00–42.00
Mean ± S.D 20.60 ± 5.68 21.00 ± 9.76 3.584 0.091
* Signiﬁcant.
312 H.A. Abu-Khaber et al.4.4.1. Statistical analysis of data
Data were analyzed using SPSS software package version 18.0
(SPSS, Chicago, IL, USA). Quantitative data were expressed
using minimum, maximum, mean, standard deviation, median,
and IQP while qualitative data were expressed in frequency
and percent. Qualitative data were analyzed using Fisher exact
and Monte Carlo test to compare different groups. Not nor-
mally distributed quantitative data were analyzed using the
Mann Whitney test for comparing two groups while for more
than two groups the Kruskal Wallis test was applied. The level
of signiﬁcance was 5.0%.
5. Results
This study was done over a period of 8 months in the critical
care department of Alexandria University in Egypt. Two
hundred and ﬁfteen patients admitted to the ICU during this
period were mechanically ventilated. Only 80 patients of them
were fulﬁlling the criteria of inclusion in the study and
accepted to be involved in the study. Those 80 patients were
randomly assigned to receive the EMS. Patients with an odd
number were assigned to the EMS group and patients with
an even number were assigned to the control group. Patients
assigned to the EMS group received daily EMS sessions of
both lower extremities starting from the second day after
admission until ICU discharge. Patients in the control group
did not receive EMS.
Baseline characteristics of continuous variables of the EMS
group and the control group for the whole cohort were com-
pared by unpaired Student’s t-test or Mann–Whitney U test
(Table 3). Qualitative variables at baseline were compared by
chi-square test. All continuous variables are presented by
mean ± standard deviation (SD). p Values of less than 0.05
were considered statistically signiﬁcant.
Table 3 showed the baseline characteristics of the two stud-
ied groups which did not show any signiﬁcant statistical
difference.
Table 4 showed a comparison between the two studied
groups regarding MRCS at different periods of follow up.
The MRCS at day 2 and day 3 were not signiﬁcantly different
between the two groups while a signiﬁcant better score was re-
corded in the EMS group at day 4 and all through till day
21.The MRCS at day 28 did not represent any statistical signif-
icant difference (p= 0.091).
Fig. 2 showed the duration of mechanical ventilation in the
two studied groups. It was 9.010 ± 8.01 days in the EMS ver-Table 3 Baseline characteristics of patients in the EMS and contro
Parameters EMS group (40 patients)
Age (years) 59.07 ± 5.32
Sex Male: 24/40 (60%) Female: 16/40 (40%)
Diagnosis:@
Type I resp. failure 7/40 (17.5%)
Type II resp. failure 15/40 (37.5%)
Type III resp. failure 13/40 (32.5%)
Type IV resp. failure 5/40 (12.5%)
Apache II 24.5 ± 6.8
@ Yates corrected Chi squares was used to calculate the p value.sus 11.97 ± 8.07 days in the control group. A signiﬁcant dif-
ference could be recorded between the two groups (p= 0.048).
Fig. 3 showed the ventilator free survival out of 28 days in
both studied groups which did not show any signiﬁcant differ-
ence between the two groups being 15.175 ± 9.65 days in the
EMS group versus 14.725 ± 9.70 days in the control group
(p= 0.421).
Table 5 showed the different outcome in the two studied
groups. The outcome was signiﬁcantly better in the EMSl groups.
Control group (40 patients) p
57.57 ± 6.80 p: 0.276
Male: 27/40 (67.5%) Female: 13/40 (32.5%) p: 0.321
5/40 (12.5%) 0.53
14/40 (35%) 0.81
16/40 (40%) 0.48
5/40 (12.5%) –
26.1 ± 5.3 0.082
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Figure 2 Comparison between the two studied groups regarding
Duration of Mechanical Ventilation (DMV).
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Figure 3 Comparison between the two studied groups regarding
Ventilator Free Survival out of 28 days (VFS).
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EMS group versus 27 patients (67.5%) in the control group.
Regarding the 28 days mortality, 4 patients (10%) died in
the EMS group versus 6 patients (15%) in the control group.
While the patients who remained ventilated at the end ofTable 5 Comparison between the two studied groups regarding ou
Outcome Group
EMS group
No. %
Weaned 31 77.5
Died (28 days mortality) 4 10.0
Still ventilated (at 28 days) 5 12.5
Total 40 100.0
X2 1.914
P 0.046*
* Signiﬁcant.28 days due to weaning failure were 5 (12.5%) in the EMS
group versus 7 (17.5%) in the control group (p= 0.046).
Regarding the complications related to the application of
electrical stimulation (EMS group), there were no major com-
plications as only 6 patients (15%) had a prickling sensation
which was not clinically signiﬁcant.
6. Discussion
Although advances in critical care and mechanical ventilation
over the past 2 decades have resulted in the increased survival
of patients who are critically ill, some patients develop the need
for prolonged mechanical ventilation (PMV). Patients requir-
ing PMV are frequently deconditioned because of respiratory
failure precipitated by the underlying disease, the adverse ef-
fects of medications, and a period of prolonged immobiliza-
tion.2,15 Patients requiring PMV often have substantial
weakness of the respiratory and limb muscles that further im-
pairs their functional status and health-related quality of life.18
Alternative care settings for patients requiring PMV have been
set up in order to wean them off the ventilator. Outcome stud-
ies in patients requiring PMV in these care units have focused
more on the weaning outcome, disposition, and survival data,
whereas only limited information is available on functional
status assessed using validated instruments.19–22
The aim of this study was to assess the effect of electrical
muscle stimulation on prevention of ICUAMW in critically
ill patients and its role in facilitating the weaning from
mechanical ventilation.
MRCS assessment for all patients started on the second day
of mechanical ventilation which was not signiﬁcantly different
between the two groups (p= 0.497). The striking ﬁnding that
MRCS values starting from day 3 post mechanical ventilation
in both groups were below 48 – which is considered as the cut-
off value for diagnosis of ICUAMW – denotes a very fast
development of muscle wasting which was shown to be pro-
gressive by time as shown by the serial decrease in MRCS val-
ues until reaching 20.6 and 21 in the EMS and control groups
respectively by the end of the study (day 28).
Our results are matching with Martin23 who reported sig-
niﬁcant limb muscle weakness in patients who were ventilator
dependent, with mean limb strength scores of less than 3 using
a 5-point Medical Research Council motor score.
In contrast to our study, is Routsi14 study which also
showed better MRCS in the EMS group compared to control
but it was different from our results on showing higher MRCS
in both groups. The MRC score was statistically signiﬁcantlytcome.
Control group Total
No. % No. %
27 67.5 58 72.5
6 15.0 10 12.5
7 17.5 12 15.0
40 100.0 80 100.0
314 H.A. Abu-Khaber et al.higher in patients assigned to the EMS group as compared
with the control group (median = 58, range = 33–60 vs med-
ian = 52, range = 2–60) (p= 0.04). This difference between
the two studies can be explained based on the different baseline
characteristics of the patients involved in the two studies. As it
is obviously noticed that our patients are much sicker than the
patients in Routsi C Study. Apache II score was around 25 in
our study while it was less than 20 in both the EMS and con-
trol group in the other study which clariﬁes the relationship be-
tween development of ICUAMW and the severity of illness not
only on the term of the degree of affection but also on how fast
this can happen in seriously ill patients.
In the same context, another study was done by Gerovasil-
i24 on forty-nine critically ill patients (age: 59 ± 21 years) with
an APACHE II admission score P13 who were randomly as-
signed after stratiﬁcation upon admission to receive daily EMS
sessions of both lower extremities (EMS-group) or to the con-
trol group (control group). Muscle mass was evaluated with
ultrasound (US), by measuring the cross sectional diameter
(CSD) of the vastus intermedius and the rectus femoris of
the quadriceps muscle. The right rectus femoris and right
vastus intermedius CSD decreased in both groups (EMS
group: from 1.42 ± 0.48 to 1.31 ± 0.45 cm, p= 0.001 control
group: from 1.59 ± 0.53 to 1.37 ± 0.5 cm, p= 0.002;
EMS group: from 0.91 ± 0.39 to 0.81 ± 0.38 cm, p= 0.001
control group: from 1.40 ± 0.64 to 1.11 ± 0.56 cm,
p= 0.004, respectively). However, the CSD of the right rectus
femoris decreased signiﬁcantly less in the EMS group (-0.11 ±
0.06 cm, 8 ± 3.9%) as compared to the control group
(0.21 ± 0.10 cm, 13.9 ± 6.4%; p< 0.05) and the CSD of
the right vastus intermedius decreased signiﬁcantly less in the
EMS group (0.10 ± 0.05 cm, 12.5 ± 7.4%) as compared
to the control group (0.29 ± 0.28 cm, 21.5 ± 15.3%;
p< 0.05). These results are matching with our results
although the method of assessment was different – MRCS as
a clinical score in our study versus ultrasound as a radiological
assessment in Gerovasili study – but both studies showed evi-
dence of deterioration in the muscle status of both groups by
time but this was more pronounced signiﬁcantly in the group
of patients who did not receive the EMS sessions (control
group).
A randomized controlled trial was done by Bourjeily25
using trans-cutaneous electrical muscle stimulation (TCEMS)
of the lower extremities in 18 medically stable patients of mean
(SD) age of 60.0 (1.5) years. Stimulation of the lower extrem-
ities was performed three times a week, 20 min each session,
for six continuous weeks. Quadriceps and hamstring muscle
strength, exercise capacity, and peak oxygen uptake were mea-
sured at baseline and after 6 weeks of stimulation. TCEMS im-
proved both the quadriceps strength (by 39.0 (20.4)% v 9.0
(8.1)%, p= 0.046) and hamstring muscle strength (by 33.9
(13.0)% v 2.9 (4.7)%, p= 0.038) in the treated (n= 9) and
non-treated (n= 9) groups, respectively. The improvement
in muscle strength carried over to better performance in the
shuttle walk test in the treated group (36.1% v 1.6% in the
treated and non-treated groups respectively, p= 0.007,
Mann–Whitney U test). There was no signiﬁcant change in
lung function, peak workload, or peak oxygen consumption
in either group. Muscle stimulation was well tolerated by the
patients with no dropouts and better than 95% compliance
with the protocol. Comparing the previous study with our
study, it could be noticed the same concept that EMS im-proved the functional status of the skeletal muscles in both
studies the main difference was in the degree of improvement
which was much more signiﬁcant in the Bourjeily study which
can be attributed to the different protocols applied and differ-
ent periods of follow up as well as the very limited number in
the study, only 18 patients––versus 80 patients in our study––
which made the absolute values of these results a matter of
question although we agreed with the overall conclusion as it
is matching with most of the results done in the same context.
Regarding the weaning of patients from mechanical ventila-
tion in our study, it was not clear whether the EMS sessions had
a really signiﬁcant role in facilitating the weaning process or not
as the number of days on mechanical ventilation showed a bet-
ter outcome on the EMS group versus the control group but the
level of statistical signiﬁcance was very weak (p= 0.048) while
the ventilator free survival out of 28 days came to be non-signif-
icant between the two groups (p= 0.421).
Our results regarding theweaning aremoreor less comparable
to the study done byRoutsi14 where the duration of mechanical
ventilation was shorter for patients assigned to the EMS group
compared with patients in the control group (median (range), 7
(2–41) vs. 10 (1–62), days, respectively), however, this differ-
ence was barely signiﬁcant (log rank test, p= 0.07). A theoret-
ical explanation for this possible effect of EMS on weaning
had been provided by Routsi study as patients assigned to
the EMS group had a shorter duration of weaning as com-
pared with patients assigned to the control group, which is a
further indication of the presence of a relation between the
limb and respiratory muscle weakness. As has been already
mentioned an acute systemic effect has been reported after
one EMS session.24 It is possible that the reported systemic ef-
fect of EMS acts as an anabolic stimulus to the respiratory
muscles as well. Generally speaking the pro-catabolic cytokine
environment that characterizes disease states associated with
inﬂammation and the critically ill, due to excessive localized
elaboration of pro-inﬂammatory cytokines26 may be altered
by EMS. A possible role is suggested for IL-6, which reduces
insulin-like growth factor 1 production, providing a major
mechanism by which chronic inﬂammation inhibits hormonal
anabolic action and affects growth.27 Exercise training reduces
IL-6 production as well as the magnitude of the acute exercise
IL-6 response and a decreased plasma IL-6 concentration, not
only in response to exercise but also at rest, appears to charac-
terize a normal exercise adaptation.28 The same mechanism,
affecting muscle protein turnover, could hold true for EMS
implementation. The shorter duration of weaning in patients
assigned to the EMS group implies a beneﬁcial effect of
EMS on the respiratory muscle function and reinforces the
clinical signiﬁcance of this study.
Inanother study conductedbyChiang5 on the effects of Phys-
ical Training on Functional Status in Patients with Prolonged
Mechanical Ventilation, the respiratory muscle strength (i.e.,
Pimax and Pemax) was similar in both groups at baseline.
At the third and sixth weeks of the study period, Pimax and
Pemax increased signiﬁcantly (p< 0.01) in the treatment
group and decreased signiﬁcantly (p< 0.001) in the control
group compared with baseline. Both Pimax and Pemax were
signiﬁcantly greater in the treatment group than in the control
group after 6 weeks of physical training. At the end of the 6-
week study period, 8 subjects (47%) in the treatment group
and 3 subjects (20%) in the control group were able to be
removed from the ventilator for at least 12 h per day. The
Effect of electrical muscle stimulation on prevention of ICU 315ventilator-free time increased an average of 8.9 h per day
(p< 0 .01) in the treatment group and 4.8 h (p< 0.1) in the
control group after 6 weeks compared with baseline.
No further studies done on the use of EMS in critically ill
patients investigated the mortality as an endpoint for assess-
ment of the beneﬁt of this technique but it seems quiet logical
that minimizing the days of mechanical ventilation and
facilitation of rapid weaning will decrease the overall compli-
cations and might have a beneﬁcial effect through reducing
mortality.
No signiﬁcant complications were encountered during the
usage of EMS; only 6 patients suffered from prickling sensa-
tion during and after the EMS sessions but this was not clini-
cally signiﬁcant to be a reason to stop the sessions. All 40
patients in the EMS group completed their sessions till the
end of the study.
Our study ﬁndings are limited by the relatively small num-
ber and heterogeneity of the patients with critical illness who
underwent an EMS session. Furthermore, sedation and the
use of drugs such as vasopressors might have affected micro-
circulation in these patients.
Future studies with larger sample sizes may allow subgroup
analysis to distinguish potential beneﬁcial effects of EMS for
different patient populations.
7. Conclusions
We can conclude from this study that ICUAMW is a very
common ﬁnding which can occur very early in the course of
mechanically ventilated critically ill patients.
The use of EMS sessions as a passive form of physiotherapy
is a safe, cheap and easily applicable technique in ICU as it
does not need patient cooperation.
Daily application of EMS sessions could not prevent the
occurrence of ICUAMW but it can minimize the degree of
weakness as shown from MRCS.
There was a tendency for easier weaning in the EMS group
versus the control group but the evidence was not statistically
signiﬁcant in such a relatively small population sample.
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